Impact of timing of atrial fibrillation, CHA2DS2-VASc score and cancer therapeutics on mortality in oncology patients.

Muzna HussainRabel MisbahEoin DonnellanSaqer AlkharabshehYuan HouFeixiong ChengMichael CrookshanksChris J WatsonAndrew J TothPenny HoughtalingRohit MoudgilG Thomas BuddW H Wilson TangDeborah H KwonWael JaberBrian GriffinMohamad KanjPatrick Collier

Published in: Open heart (2021)

This study reports a nuanced/complex relationship between AF and cancer. First diagnosis of AF in patients with cancer was more common at/early after cancer diagnosis, especially in older patients and those exposed to cardiotoxic treatment. Pre-existing AF or a diagnosis of AF within 3 years after cancer diagnosis carried a negative prognosis. CHA2DS2-VASc score did not relate to mortality in those that developed AF within 3 years of cancer diagnosis.

Keyphrases

atrial fibrillation
papillary thyroid
squamous cell
emergency department
heart failure
left atrial
cardiovascular events
oral anticoagulants
palliative care
risk factors
small molecule
coronary artery disease
newly diagnosed
percutaneous coronary intervention
patient reported outcomes